Save over 55% on brand name Calquence made in Europe. Generic Calquence is available at 90% discount over the brand name medicine.
For more information on generics from MSN Laboratories click here
All brand Calquence is manufactured at by AstraZeneca AB Gärtunavägen SE-152 57 Södertälje Sweden
Information about Calquence (Acalabrutinib)
Calquence is a prescription medication containing acalabrutinib, a targeted therapy used primarily to treat certain types of blood cancers. It is a Bruton's tyrosine kinase (BTK) inhibitor, which works by interfering with the signals that help cancer cells grow and survive. Calquence is primarily used in the treatment of chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL), among other B-cell malignancies.
Product Highlights
- Acalabrutinib specifically targets Bruton's tyrosine kinase, a protein crucial for the growth and survival of cancer cells.
- Works by blocking specific pathways involved in cancer cell proliferation, potentially leading to fewer off-target effects compared to traditional chemotherapy.
Key Ingredient
Key Benefits
- Proven to be effective in treating CLL and SLL, with benefits in terms of progression-free survival.
- Administered orally, which can be more convenient compared to intravenous treatments.
- Specifically targets cancer cells with fewer impacts on non-cancerous cells, potentially leading to a different side effect profile compared to traditional therapies.
Direction of Use
- Follow the exact dosage prescribed by your healthcare provider. The typical dosage is one tablet twice daily.
- Take the tablet orally with or without food. Swallow the tablet whole; do not chew, crush, or split it.
- Take the medication at the same times each day to maintain steady levels in your bloodstream. Do not miss doses, and if you miss a dose, take it as soon as possible unless it is close to the time for your next dose.
Safety Concerns
- May include headache, diarrhea, fatigue, rash, and nausea.
- Watch for more severe side effects such as bleeding problems, infections, heart rhythm issues, or liver abnormalities. Report symptoms like unusual bleeding or bruising, persistent fever, or jaundice to your healthcare provider immediately.
- Can interact with other medications, including certain anticoagulants, antifungals, and antacids. Inform your healthcare provider of all other medications, including over-the-counter drugs and supplements.
Avoid Calquence (Acalabrutinib) If
- You are allergic to acalabrutinib or any of the inactive ingredients in Calquence.
- If you have a bleeding disorder or are taking medications that increase bleeding risk, consult with your healthcare provider, as acalabrutinib may increase bleeding risk.
- Those with severe liver impairment should avoid using this medication or use it under strict medical supervision due to the risk of liver-related side effects.
- Avoid if taking medications that interact significantly with acalabrutinib, as this can affect drug levels and efficacy.
